Worldwide: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

L'Agence des médicaments du Canada annonce une consultation sur le processus d'examen simplifié et de nouvelles procédures en ce qui concerne les reconsidérations et les nouvelles demandes d'examen

Le 29 janvier 2026, l'Agence des médicaments du Canada (l'« AMC ») a publié des Améliorations au processus d'examen en vue du remboursement d'un médicament...

Canada Healthcare

SB

Smart & Biggar

Proposed Regulatory Framework Aims To Better Support Innovative Clinical Trials In Canada

In December 2025, Health Canada released proposed Clinical Trials Regulations (the proposed regulations), which would establish a new regulatory framework for clinical trials involving drugs for human use.

Canada Healthcare

TL

Torys LLP

Canada's Drug Agency Announces Consultation On Streamlined Review Process And New Reconsideration/resubmission Procedures

On January 29, 2026, Canada's Drug Agency (CDA) published Improvements to the Drug Reimbursement Review Process, which includes a section for consultation on proposed changes to the reimbursement review process.

Canada Healthcare

SB

Smart & Biggar

Canadian Product Stewardship And EPR: A Review Of 2025 And Beyond

In 2025, Canadian governments and producer‑responsibility organizations ("PROs") continued advancing innovative product stewardship and extended producer responsibility...

Canada Environment

GW

Gowling WLG

New PMPRB Chairperson And PMPRB Releases January 2026 NEWSletter

Canada Healthcare

SB

Smart & Biggar

Nouvelle présidente au CEPMB et publication de l'édition de janvier 2026 de la Nouvelle du CEPMB

SB

Smart & Biggar

Legislative Update Report No. 2026-04 Le Bulletin D'actualités Législatives

Canada Government

OH

Osler, Hoskin & Harcourt LLP

Ce Que Les Organismes De Santé Doivent Savoir Sur Les Nouvelles Directives Entourant La Transcription Par IA En Ontario, En Colombie-Britannique Et En Alberta

Canada Technology

BL

Borden Ladner Gervais LLP

Health Canada Introduces New Efforts To Expedite Review Of Drug Submissions

Canada Healthcare

TL

Torys LLP

Proposed Ministerial Reliance Order Would Allow Health Canada To Rely On Decisions Of Foreign Trusted Regulators

Canada Healthcare

SB

Smart & Biggar

Revue de l'année 2025 en droit des brevets au Canada

SB

Smart & Biggar

Les 10 articles incontournables de la Mise à jour en PI Rx en 2025

Canada Healthcare

SB

Smart & Biggar

Zero-Rated Or Taxable Food & Drinks?

MK

Millar Kreklewetz

Canadian Trademark Law Year In Review 2025: Notable Decisions And Updates

C

Cassels

AI Washing: The New Greenwashing — How The SEC's Emerging Technologies Unit Is Rewriting The Compliance Landscape

Canada Technology

ML

McMillan LLP

Canada's Vulnerable Worker Open Work Permit: What's New And Why It Matters

Canada Employment

Moving2Canada

New Framework For Canadian AI Governance: IPC–OHRC Principles

Canada Technology

TM

Torkin Manes LLP

CRA Introduces Software-Specific Controls For EFILE Accounts, A Safety Feature, Starting In 2026

RS

Rotfleisch & Samulovitch P.C.

Evolving Needs For Emerging And High Growth Companies: Series A Stage (Video)

Canada Commercial

OH

Osler, Hoskin & Harcourt LLP

The Canada Mutual Recognition Agreement – A Two-Way Street To The Market

The signing of the Canadian Mutual Recognition Agreement on the Sale of Goods (the CMRA) marked an important day for federal and provincial trade within Canada.

FR

Fillmore Riley

Double brevet et demandes divisionnaires au Canada : des stratégies évolutives pour les demandeurs

En pratique divisionnaire, le double brevet et l'unité d'invention constituent des questions centrales dans les procédures d'octroi de brevets auprès des différents territoires, mais les stratégies à...

SB

Smart & Biggar

Service Of Process: More Than A Formality

Plaintiffs usually start lawsuits by serving the defendant personally with a statement of claim. While personal service is the "gold standard," Ontario's Rules of Civil Procedure permit alternative...

Canada Litigation

C

Cassels

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

In September, we provided our eighth annual update following the significant September 2017 amendments to the PM(NOC) Regulations.

Canada Healthcare

SB

Smart & Biggar

Les faits saillants de 2025 au Canada en matière de PI en sciences de la vie et de droit réglementaire

Canada Healthcare

SB

Smart & Biggar

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Class Action Pursued Concerning Safety Defects With GLP-1 Drugs Mounjaro, Trulicity, & Zepbound

Canada Litigation

SL

Siskinds LLP

Federal Court Of Appeal Confirms BYOOVIZ Is Confusing With Novartis' BEOVU Trademark

SB

Smart & Biggar

Santé Canada lance une consultation sur deux documents d'ébauche de lignes directrices sur les conditions pour les médicaments à usage humain et vétérinaire ainsi que les présentations de drogues basées sur des preuves prometteuses d'efficacité clinique

Canada Healthcare

SB

Smart & Biggar

Proposal For Modernizing Clinical Trial Framework Aims To Improve Access To New And Innovative Therapies In Canada

Canada Healthcare

SB

Smart & Biggar

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Canada Healthcare

SB

Smart & Biggar

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Canada Healthcare

SL

Siskinds LLP

Legislative Update Report No. 2025-24 Le Bulletin D'actualités Législatives

Canada Government

OH

Osler, Hoskin & Harcourt LLP

Naming Natural Health Products: Branding In A Grey Zone

Canada Healthcare

ML

McMillan LLP

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Le 20 décembre 2025, Santé Canada a lancé une consultation sur la modernisation du cadre des essais cliniques visant les médicaments destinés à l'usage des humains...

Canada Healthcare

SB

Smart & Biggar

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Patients who have been diagnosed with tumours or cancers after using pharmaceutical or health products may be able to pursue legal claims against manufacturers when credible scientific...

Canada Healthcare

SL

Siskinds LLP

Legislative Update Report No. 2025-24 Le Bulletin D'actualités Législatives

Osler's Legislative Update is a bi-weekly listing of new legislation. This issue covers legislation for the period 12/12 to 12/24.

Canada Government

OH

Osler, Hoskin & Harcourt LLP

Naming Natural Health Products: Branding In A Grey Zone

Over the course of our previous bulletins, we have examined branding considerations for prescription drugs, over-the-counter drugs, and medical devices.

Canada Healthcare

ML

McMillan LLP

Liability Of Police Chiefs & Police Boards For Officer Misconduct: Rivard V. Ontario, 2025 ONCA 100

Canada Litigation

AH

Alexander Holburn Beaudin + Lang LLP

How Is AI Transforming The Life Sciences Industry?

Stakeholders are grappling with the numerous opportunities and risks presented by the convergence of artificial intelligence and tools designed for the development of novel therapeutics and the delivery of health care.

Canada Technology

TL

Torys LLP

Les lignes directrices définitives du CEPMB sur le prix des médicaments brevetés entrent en vigueur le 1er janvier 2026 : ce que cela signifie pour les entreprises pharmaceutiques innovantes

À compter du 1er janvier 2026, le Conseil d'examen du prix des médicaments brevetés (CEPMB) mettra en œuvre de nouvelles Lignes directrices pour la surveillance des prix des médicaments brevetés au Canada.

MT

McCarthy Tétrault LLP

What You Should Know About The Freestyle Libre 3 Recall

There is little doubt that medical technology has dramatically enhanced the quality and longevity of our lives. We continue to see innovations that not only aid in earlier detection of disease...

Worldwide Litigation

GP

Gluckstein Lawyers

VC Investment In Canada For Life Sciences Companies

Despite recent pullbacks in biotechnology and life sciences venture capital ("VC") funding in Canada, a more in-depth analysis reveals strong indicators of investment demand...

Canada Healthcare

MT

McCarthy Tétrault LLP

Taking Action On Food Insecurity

Canada Healthcare

ML

McMillan LLP

Final Patented Medicines Pricing Guidelines From The PMPRB Take Effect On January 1, 2026: What This Means For Innovative Pharma

MT

McCarthy Tétrault LLP

Canadian Patent Law In Review 2025: Notable Decisions And Updates

C

Cassels

Santé Canada et la Food and Drug Administration des États-Unis conviennent de mettre en place un programme de partage d'informations pour l'examen des médicaments génériques

Canada Healthcare

SB

Smart & Biggar

L'Agence des médicaments du Canada publie une nouvelle ressource et des données sur le processus d'autorisation et de remboursement des médicaments

Canada Healthcare

SB

Smart & Biggar

Health Canada And U.S. FDA Agree To Establish Information Sharing Program For Generic Drug Submission Reviews

Canada Healthcare

SB

Smart & Biggar

Canada's Drug Agency Releases New Resource And Data On Drug Approval And Reimbursement Pathway

SB

Smart & Biggar

Final Changes To Quebec's Exceptional Patient Measure To Come Into Effect

Canada Healthcare

F

Fasken

How To Find The Risks Linked To Your Prescriptions

Canada Healthcare

SL

Siskinds LLP

Tis The Season For Holiday Parties At Work And At Home

Canada Litigation

GP

Gluckstein Lawyers

St. Catharines v. Al-Kadhee – Closing Order Application Unburdens Community Of Problem House

Canada Real Estate

BA

Boghosian + Allen

The Rise Of Unionization In Canada: Strategies For Employers In A Post-pandemic World

Canada Employment

MT

Miller Thomson LLP

The BC Supreme Court Reinforces A Plaintiff's Duty To Exercise A Modicum Of Awareness For Their Own Safety In Petrunia v. Pensionfund Realty Limited, 2025 BCSC 2345

Canada Litigation

CC

CLC (Canadian Litigation Counsel)

L'APP lance une voie révisée pour les négociations non complexes concernant le prix de médicaments

Canada Healthcare

SB

Smart & Biggar

December 2025 Rosen Sunshine Newsletter

Canada Healthcare

RS

Rosen Sunshine LLP

See more

Latest Videos

See more

From Discovery To Market: The Role Of IP Strategy In Drug Development (Video)

GW

Gowling WLG

Pricing And Reimbursement: Federal Drug Price Control

TL

Torys LLP

Le Secteur De La Santé Au Canada Après La COVID-19 : Perspectives Juridiques, Médicales Et Commerciales (vidéos)

SE

Stikeman Elliott LLP

Cannabis 2.0 Rollout: Edibles, Extracts Legalized (Video)

BC

Blake, Cassels & Graydon LLP

Emerging Growth And Venture Technology Video Series Part Two: Weed Growth (Video)

D

Dentons Canada LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More